Telbivudine in chronic lymphocytic myocarditis and human parvovirus B19 transcriptional activity

AIMS: Myocarditis is often associated with parvovirus B19 (B19V) persistence, which can induce vascular damage. Based on the antiviral and anti‐inflammatory properties of telbivudine, we aimed to evaluate its efficacy to protect B19V‐infected endothelial cells in vitro and to treat chronic lymphocyt...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:ESC Heart Fail
Egile Nagusiak: Van Linthout, Sophie, Elsanhoury, Ahmed, Klein, Oliver, Sosnowski, Marzena, Miteva, Kapka, Lassner, Dirk, Abou‐El‐Enein, Mohamed, Pieske, Burkert, Kühl, Uwe, Tschöpe, Carsten
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2018
Gaiak:
Original Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6165949/
https://ncbi.nlm.nih.gov/pubmed/30099854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12341
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak